Stoke Therapeutics, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
STOK Company Description
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S.
STOK Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view STOK Smart Score
Score Breakdown
STOK Company Description
Show More
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its first compound, STK-001, is in clinical testing for the treatment of Dravet syndrome, a severe and progressive genetic epilepsy. The company primarily operates in the U.S. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of STOK by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by STOK's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on STOK's company Twitter account
WallStreetBets
Number of mentions of STOK in WallStreetBets Daily Discussion
STOK News
Recent insights relating to STOK
CNBC Recommendations
Recent picks made for STOK stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in STOK
Corporate Flights
Flights by private jets registered to STOK
Our Analysis